Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medx Health Corp MDXHF


Primary Symbol: V.MDX

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and,... see more

TSXV:MDX - Post Discussion

Medx Health Corp > Pivoting excellence
View:
Post by hopefull on Jun 04, 2024 5:23pm

Pivoting excellence

No doubt this company has mastered the pivot.
Unfortunately the lack of full investigation into a particular market has been there down fall.
Wondering after sheer volume of pivots these guys have made is the UK Health Partners just another bad choice .
Since the proclamation of "the biggest P O for Brazil" the sheer private investor money raised in comparison to the sales generated from the Dermsecure/ SIAscope platform is staggering and based on the fact Medx is really having a hard time finding anyone outside to invest you wonder how this company can survive. 
Just land one deal and show sales and show contracts then investors will be there 

But it's Peter and the wolf consistently.
Sad that the board still supports the same approach consistently, expecting different results.
Be the first to comment on this post
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse